Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology ...Middle East

Investment led by Esperante Ventures and Ferring Ventures: Additional funding to support expanded SPT-2101 clinical trial. Progress with SPT-2101 for Meniere's Disease: Encouraging data from the Australian clinical trial validates Spiral's proprietary drug delivery platform, with plans to...

Read More Details
Finally We wish PressBee provided you with enough information of ( Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology )

Also on site :

• Fresh sirens in north Israel warning of Iran missiles: army
• Target's 'Top-Selling' $5 Backpack Is Heading Back to Stores This Year
• SMB-focused Finom closes €115M as European fintech heats up